Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Regeneron Pharmaceuticals Inc

+ Add to Watchlist

REGN:US

412.505 USD 5.935 1.42%

As of 20:10:00 ET on 03/03/2015.

Company Profile for Regeneron Pharmaceuticals Inc (REGN)

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.

Contact Information

Regeneron Pharmaceuticals Inc

777 Old Saw Mill River Road
Tarrytown, NY 10591-6707
United States
Phone: 1-914-847-7000
Fax: 1-914-347-2847

Key Executives for Regeneron Pharmaceuticals Inc (REGN)

Leonard S Schleifer "Len"President/CEO/Co-FounderGeorge D YancopoulosPres:Laboratories
Joseph J Larosa "Joe"Senior VP/Secy/General CounselDaniel P Van PlewSenior VP/Gen Mgr:Industrial Ops
Robert E Landry Jr "Bob"Senior VP:Finance/CFOMurray A GoldbergSenior VP:Administration
Robert J TerifaySenior VP:CommercialPeter PowchikSenior VP:Clinical Development
Neil StahlSenior VP:Research & DevDouglas S McCorkleVP/Asst Treasurer/Controller
Michael AbermanVP:Investor RelationsJoanne DeyoVP:Facilities

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil